OFIX - Orthofix Medical Inc. (OFIX) Q4 2023 Earnings Call Transcript

2024-03-05 22:35:26 ET

Orthofix Medical Inc. (OFIX)

Q4 2023 Earnings Conference Call

March 05, 2024 04:30 PM ET

Company Participants

Louisa Smith - Vice President of Gilmartin Group

Massimo Calafiore - President and Chief Executive Officer

Julie Andrews - Chief Financial Officer

Conference Call Participants

Mathew Blackman - Stifel

Ryan Zimmerman - BTIG

Destiny Hance - Ladenburg Thalmann

Jason Wittes - Roth MKM

Presentation

Operator

Good afternoon, and welcome to Orthofix Medical’s Q4 and Full Year 2023 Earnings Call. All participants are in a listen-only mode. After the speakers' remarks, we will have a question-and-answer session. [Operator Instructions] As a reminder, this conference call is being recorded.

I would now like to turn the call over to Louisa Smith, Vice President of Gilmartin Group. Thank you. Please go ahead.

Louisa Smith

Good afternoon, everyone. Welcome to the Orthofix fourth quarter 2023 earnings call. Joining me on the call today are President and Chief Executive; Massimo Calafiore, and Chief Financial Officer, Julie Andrews.

During this call, we will make forward-looking statements that involve risks and uncertainties. All statements other than those of historical facts are forward-looking statements including any earnings guidance we provide and any statements about our plans, beliefs, strategies, expectations, goals or objectives. Investors are cautioned not to place undue reliance on such forward-looking statements as there is no assurance that the matter contained in such statements will occur. The forward-looking statements we will make on today's call are based on our beliefs and expectations as of today, March 5, 2024.

We do not undertake any obligation to revise or update such forward looking statements. Some factors that could cause actual results to be materially different from the forward-looking statements made by us on the call include the risk factors disclosed under the heading Risk Factors in our Form 10-K filed this afternoon, March 5, 2024, for the year ended December 31, 2023 as well as additional SEC filings we make in the future....

For further details see: